Consequently, it may be hypothesized that patients with long-term antibiotic therapy for EGFR inhibitors papulo-pustular rash who undergo a therapeutic switch towards immunotherapy, may have an inferior response compared to antibiotic naive patients. The gene discussed is EGFR; the disease is exanthem.